CPRIT in the News
Margaret Kripke Selected as AACR Academy Fellow
CPRIT Chief Scientific Officer Dr. Margaret Kripke has been selected to join the inaugural class of the Fellows of the American Association for Cancer Research Academy. The inaugural class includes 106 individuals recognized as distinguished scientists whose major scientific contributions have lead to significant innovation and progress against cancer. The inaugural Fellows will be inducted into the AACR Academy at the AACR Annual Meeting in April 2013.
Letter to the Editor: Houston
Dorothy Gibbons, CEO and Co-Founder of The Rose, a CPRIT Prevention award recipient, reflects on her testimony before the Texas Legislature on CPRIT funding.
Cancer Advocates Wait for CPRIT Moratorium to End
Cancer advocates from across the state weigh in on the grant moratorium and the future of the agency.
State Money Trying to Reverse Flow of Cancer Research Leaving Texas
David G. Lowe, a California venture capitalist, and George Georgiou at the University of Texas, a CPRIT Research award recipient, share how "CPRIT financing has gotten people’s attention."
Friend to Friend Event Well Attended
More than 75 women throughout Parker County received breast and cervical cancer prevention education through Texas A&M AgriLife Extension Service’s Friend to Friend Staying Healthy Together Program, a best practice initiative funded by CPRIT. The Friend to Friend project offers a coordinated approach to education, screening, diagnosis, and referrals for women who are uninsured and over 65 years of age living in 49 frontier, rural, and border counties in Texas.
Pre-Transplant Umbilical Cord Blood Expansion in Lab Speeds Establishment of New Blood Supply in Pat
Researchers working on a project partially funded by CPRIT report in the December 13 edition of the New England Journal of Medicine that donated umbilical cord blood establishes a new blood supply in patients more quickly after transplantation when it is first expanded in the lab on a bed of cells that mimics conditions in the bone marrow. The phase 1/2 study led by scientists at The University of Texas MD Anderson Cancer Center addresses the main difficulty with using umbilical cord blood stem cells to replace the blood supply of patients who have had theirs destroyed by chemotherapy or radiation to treat leukemia, lymphoma and other blood- based diseases.
Cancer institute strives to pave quick pathway to patients
Thanks to the Chronicle for presenting Todd Ackerman and Eric Berger's Nov. 10 story reporting University of Texas System Chancellor Francisco Cigarroa's and the UT Board of Regents' unqualified support and confidence in Ronald A. DePinho, M.D., president of the M.D. Anderson Cancer Center. Also, thanks for the Nov. 11 Chronicle essay by Bill Gimson reporting on the background and progress of the Cancer Prevention and Research Institute of Texas' mission and goals. These two pieces together go a long way toward correcting some of the false impressions that have been created by statements previously reported in the Chronicle from individuals no longer associated with CPRIT.
Key discovered to how chemotherapy drug causes heart failure
Scientists at MD Anderson, working on a project partially funded by CPRIT, have discovered the reasons behind cancer drug Doxorubicin's damage to cancer patients' hearts, allowing for easier identification of patients who can safely use it to kill tumors.
Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline in
Cancer development and commercialization company Mirna Therapeutics announced a new round of funding that positions the company to make greater strides in using microRNA therapies to fight cancer.
Why Texas’ growth still draws high achievers
Did you know that CPRIT has granted $130 million to help bring 43 top-notch cancer researchers to Texas? An article in Saturday's Dallas Morning News highlights researchers' "chance to build something" by relocating to Texas. These experts cited Texas' population growth, commitment to its infrastructure and the "opportunity to do big things" as reasons for coming to the Lone Star State.
